[1] Madani T, Mohammadi Yeganeh L, Ezabadi Z, et al. Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial[J]. J Assist Reprod Genet,2013,30(2):239-245.
[2] Nargund G, Hutchison L, Scaramuzzi R, et al. Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles[J]. Reprod Biomed Online,2007,14(6):682-685.
[3] Kashyap S, Parker K, Cedars MI, et al. Ovarian hyperstimulation syndrome prevention strategies: reducing the human chorionic gonadotropin trigger dose[J]. Semin Reprod Med, 2010,28(6):475-485.
[4] 关小红, 张爱军, 陆小溦,等. 体质量指数对体外受精-胚胎移植结局的影响[J]. 上海交通大学学报(医学版),2010,30(5):597-600.
[5] 林仙华, 叶碧绿, 赵军招,等. 基础FSH/LH比值对年轻不孕患者IVF-ET周期卵巢反应性的影响[J]. 现代妇产科进展,2006,15(12):930-933.
[6] Tsoumpou I, Muqlu J, Gelbaya TA, et al. Symposium: Update on prediction and management of OHSS Optimal dose of HCG for final oocyte maturation in IVF cycles: absence of evidence? [J]. Reprod Biomed Online, 2009,19(1):52-58.
[7] Schmidt DW, Maier DB, Nulsen JC, et al. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization[J]. Fertil Steril,2004,82(4):841-846.
[8] Kolibianakis EM, Papanikolaou EG, Tournaye H, et al. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone[J]. Fertil Steril,2007,88(5):1382-1388.
[9] Lin H, Wang W, Li Y, et al. Triggering final oocyte maturation with reduced doses of hCG in IVF/ICSI: a prospective, randomized and controlled study[J]. Eur J Obstet Gynecol Reprod Biol,2011,159(1):143-147.
(2013-07-04收稿 2013-12-05修回) |